Kenneth Zahka

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial”.

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01505-4

N/A

3.8DataRank · unranked

134 citations

Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more

Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Circulation Heart Failure(2024)10.1161/circheartfailure.124.011663

N/A

0.328DataRank · unranked

7 citations

Danielle S. Burstein, Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka +19 more

Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency

Genetics in Medicine(2021)10.1016/j.gim.2021.10.014

N/A

0DataRank · unranked

4 citations

Siying Lin, Promita Ghosh, Francesca Clementina Radio, Emily Farrow, Isabelle Thiffault +35 more

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010314

N/A

0DataRank · unranked

1 citations

Mitra Mastali, Jennifer E. Van Eyk, E. John Orav, Christoffer Rasmus Vissing, Sharlene M. Day +27 more